Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL.

J Am Soc Nephrol. 2015 Oct;26(10):2534-44. doi: 10.1681/ASN.2014070686. Epub 2015 Apr 2.

2.

Circadian variation of mineral and bone parameters in end-stage renal disease.

Trivedi H, Szabo A, Zhao S, Cantor T, Raff H.

J Nephrol. 2015 Jun;28(3):351-9. doi: 10.1007/s40620-014-0124-6. Epub 2014 Aug 20.

3.

Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.

Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1254-62. doi: 10.2215/CJN.09470913. Epub 2014 Jun 19.

4.

Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms.

D'Amour P, Rousseau L, Hornyak S, Yang Z, Cantor T.

Int J Endocrinol. 2011;2011:469783. doi: 10.1155/2011/469783. Epub 2011 Jun 22.

5.

Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.

Caron P, Simonds WF, Maiza JC, Rubin M, Cantor T, Rousseau L, Bilezikian JP, Souberbielle JC, D'Amour P.

Clin Endocrinol (Oxf). 2011 Jun;74(6):694-8. doi: 10.1111/j.1365-2265.2011.04021.x.

6.

Locum issues. The elephant in out of hours primary care.

Cantor TJ.

BMJ. 2010 Jul 21;341:c3881. doi: 10.1136/bmj.c3881. No abstract available.

PMID:
20659995
7.

Rat parathyroid hormone (rPTH) ELISAs specific for regions (2-7), (22-34) and (40-60) of the rat PTH structure: influence of sex and age.

D'Amour P, Rousseau L, Hornyak S, Yang Z, Cantor T.

Gen Comp Endocrinol. 2010 Sep 15;168(3):312-7. doi: 10.1016/j.ygcen.2010.07.002. Epub 2010 Jul 11.

PMID:
20627105
8.

Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages.

Patel S, Barron JL, Mirzazedeh M, Gallagher H, Hyer S, Cantor T, Fraser WD.

J Bone Miner Metab. 2011 Jan;29(1):71-9. doi: 10.1007/s00774-010-0192-1. Epub 2010 Jun 3.

PMID:
20521154
9.

Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.

Herberth J, Branscum AJ, Mawad H, Cantor T, Monier-Faugere MC, Malluche HH.

Am J Kidney Dis. 2010 May;55(5):897-906. doi: 10.1053/j.ajkd.2009.12.041. Epub 2010 Mar 27.

10.

Commentary.

Cantor T.

Clin Chem. 2009 Sep;55(9):1740. doi: 10.1373/clinchem.2009.131409. No abstract available.

11.

The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.

Herberth J, Monier-Faugere MC, Mawad HW, Branscum AJ, Herberth Z, Wang G, Cantor T, Malluche HH.

Clin Nephrol. 2009 Jul;72(1):5-14.

12.
13.

Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.

Fehmi H, Osman Y, Bhat S, Nguyen K, Daramola O, Cantor T, Monier-Faugere MC, Yee J, Malluche HH.

Clin Nephrol. 2009 Mar;71(3):267-75.

PMID:
19281737
14.

Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves' disease.

Kai M, Yamashita H, Cantor T, Moriyama T, Rai M, Ogawa T, Watanabe S, Uchino S, Noguchi S.

Surg Today. 2008;38(3):214-21. doi: 10.1007/s00595-007-3597-2. Epub 2008 Feb 29.

PMID:
18306994
15.

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.

Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.

Nephrol Dial Transplant. 2008 May;23(5):1650-8. Epub 2007 Dec 8.

PMID:
18065788
16.

Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.

Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M.

Clin J Am Soc Nephrol. 2006 May;1(3):525-31. Epub 2006 Apr 5.

17.

iPTH Treatment Guidelines for Caucasian versus African-American Hemodialysis Patients.

Cantor TL.

Semin Dial. 2007 Jul-Aug;20(4):370-1. No abstract available.

PMID:
17635832
18.

An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.

Rubin MR, Silverberg SJ, D'Amour P, Brossard JH, Rousseau L, Sliney J Jr, Cantor T, Bilezikian JP.

Clin Chem. 2007 Aug;53(8):1470-6. Epub 2007 Jun 28.

20.
21.

Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.

D'Amour P, Räkel A, Brossard JH, Rousseau L, Albert C, Cantor T.

J Clin Endocrinol Metab. 2006 Jan;91(1):283-9. Epub 2005 Oct 11.

PMID:
16219713
22.
23.

Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.

Räkel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P.

Clin Endocrinol (Oxf). 2005 Jun;62(6):721-7.

PMID:
15943835
24.

Parathyroid hormone and growth in children with chronic renal failure.

Waller SC, Ridout D, Cantor T, Rees L.

Kidney Int. 2005 Jun;67(6):2338-45.

25.

Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.

Yamashita H, Cantor T, Uchino S, Watanabe S, Ogawa T, Moriyama T, Takamatsu Y, Fukagawa M, Noguchi S.

World J Surg. 2005 Feb;29(2):169-73.

PMID:
15650804
26.

Differences between "intact" PTH and 1-84 PTH assays in chronic renal failure and dialysis.

Waller S, Ridout D, Cantor T, Rees L.

Pediatr Nephrol. 2005 Feb;20(2):197-9. Epub 2004 Dec 31.

PMID:
15627166
27.

Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.

D'Amour P, Brossard JH, Räkel A, Rousseau L, Albert C, Cantor T.

Clin Chem. 2005 Jan;51(1):169-76. Epub 2004 Oct 28.

28.

The opposing actions of the two parathyroid hormones, 1-84 PTH and 7-84 PTH: improvement in renal bone and calcium metabolism management.

Cantor TL.

Hemodial Int. 2004 Oct 1;8(4):372-85. doi: 10.1111/j.1492-7535.2004.80414.x.

PMID:
19379445
29.
30.

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.

Kazama JJ, Omori K, Higuchi N, Takahashi N, Ito Y, Maruyama H, Narita I, Cantor TL, Gao P, Gejyo F.

Nephrol Dial Transplant. 2004 Apr;19(4):892-7.

PMID:
15031346
31.

Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.

Kifor O, McElduff A, LeBoff MS, Moore FD Jr, Butters R, Gao P, Cantor TL, Kifor I, Brown EM.

J Clin Endocrinol Metab. 2004 Feb;89(2):548-56.

PMID:
14764760
32.

Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism.

Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H, Fukagawa M.

Surgery. 2004 Feb;135(2):149-56.

PMID:
14739849
33.
34.

Parathyroid hormone and its fragments in children with chronic renal failure.

Waller S, Reynolds A, Ridout D, Cantor T, Gao P, Rees L.

Pediatr Nephrol. 2003 Dec;18(12):1242-8. Epub 2003 Oct 24.

PMID:
14579141
35.

Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.

Silverberg SJ, Gao P, Brown I, LoGerfo P, Cantor TL, Bilezikian JP.

J Clin Endocrinol Metab. 2003 Oct;88(10):4725-30.

PMID:
14557447
36.

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

Ureña P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC.

Nephrol Dial Transplant. 2003 Nov;18(11):2325-31.

PMID:
14551361
37.

Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays.

Santamaria R, Almaden Y, Felsenfeld A, Martin-Malo A, Gao P, Cantor T, Aljama P, Rodriguez M.

Kidney Int. 2003 Nov;64(5):1867-73.

38.

Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans.

Yamashita H, Gao P, Cantor T, Futata T, Murakami T, Uchino S, Watanabe S, Kawamoto H, Fukagawa M, Noguchi S.

Eur J Endocrinol. 2003 Oct;149(4):301-6.

PMID:
14514344
39.

Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas.

Kifor O, Kifor I, Moore FD Jr, Butters RR Jr, Cantor T, Gao P, Brown EM.

J Clin Endocrinol Metab. 2003 Sep;88(9):4455-64.

PMID:
12970324
41.

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T.

Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8.

PMID:
12771313
42.

Validation and clinical utility of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone in the horse.

Estepa JC, Garfia B, Gao PR, Cantor T, Rodriguez M, Aguilera-Tejero E.

Equine Vet J. 2003 May;35(3):291-5.

PMID:
12755433
43.

Dynamics of secretion and metabolism of PTH during hypo- and hypercalcaemia in the dog as determined by the 'intact' and 'whole' PTH assays.

Estepa JC, Lopez I, Felsenfeld AJ, Gao P, Cantor T, Rodríguez M, Aguilera-Tejero E.

Nephrol Dial Transplant. 2003 Jun;18(6):1101-7.

PMID:
12748341
44.

A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.

Kifor O, Moore FD Jr, Delaney M, Garber J, Hendy GN, Butters R, Gao P, Cantor TL, Kifor I, Brown EM, Wysolmerski J.

J Clin Endocrinol Metab. 2003 Jan;88(1):60-72.

PMID:
12519831
45.

Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay.

Yamashita H, Gao P, Noguchi S, Cantor T, Uchino S, Watanabe S, Yamashita H, Kawamoto H, Fukagawa M.

Ann Surg. 2002 Jul;236(1):105-11.

46.

Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.

Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, Gao P, Cantor T, D'Amour P.

Eur J Endocrinol. 2002 Jul;147(1):123-31.

PMID:
12088929
47.

High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients.

Salomon R, Charbit M, Gagnadoux MF, Niaudet P, Gao P, Cantor T, Souberbielle JC.

Pediatr Nephrol. 2001 Dec;16(12):1011-4.

PMID:
11793090
48.

Health inequalities and deprivation.

Cantor TJ.

Br J Gen Pract. 2001 Sep;51(470):754; author reply 755. No abstract available.

49.

Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

Nakanishi S, Kazama JJ, Shigematsu T, Iwasaki Y, Cantor TL, Kurosawa T, Fukagawa M.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S172-4.

PMID:
11576948
50.

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.

Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH.

Kidney Int. 2001 Oct;60(4):1460-8.

Supplemental Content

Loading ...
Support Center